Figure 2: Select association between microbiome diversity and clinical outcomes.

a) Visualization of the cumulative incidence of non-relapse mortality, separated by the tertiles of microbial diversity at engraftment. b) Kaplan-Meier probability curves for overall survival, separated by the tertiles of microbial diversity at baseline. c) Kaplan-Meier probability curves for GVHD-free, relapse-free survival (GRFS), separated by the tertiles of microbial diversity at baseline. All p-values were derived from Fine-Gray or Cox regression models.